Atea Pharmaceuticals, Inc. (AVIR)

Atea Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	267	254	401	743	3,452	-
Market Cap Growth	13.04%	-36.48%	-46.08%	-78.48%	-	-
Enterprise Value	-214	-338	-261	-96	3,522	-
Last Close Price	3.16	3.05	4.81	8.94	41.78	-
PE Ratio	-	-	-	6.53	-	-
PS Ratio	-	-	-	2.11	70.98	-
PB Ratio	0.58	0.46	0.63	1.05	6.30	-
P/TBV Ratio	0.62	0.46	0.63	1.05	6.30	-
P/FCF Ratio	-	-	-	-	11.63	-
P/OCF Ratio	-	-	-	-	11.63	-
EV/Sales Ratio	-	-	-	-	72.42	-
EV/FCF Ratio	-	-	-	-	11.87	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	-	-
Debt / EBITDA Ratio	-	-	-	0.00	-	-
Asset Turnover	-	-	-	0.43	0.11	-
Quick Ratio	19.17	18.04	35.00	13.44	2.71	8.90
Current Ratio	19.33	18.24	35.77	13.58	2.73	9.00
Return on Equity (ROE)	-33.45%	-22.74%	-17.16%	19.27%	-3.86%	-53.47%
Return on Assets (ROA)	-14.25%	-11.89%	-9.65%	10.57%	-1.56%	-32.07%
Return on Capital (ROIC)	-14.99%	-12.49%	-10.26%	13.75%	-2.43%	-34.78%
Earnings Yield	-65.19%	-53.43%	-28.93%	16.31%	-0.32%	-
FCF Yield	-47.56%	-33.56%	-30.68%	-11.71%	8.60%	-
Buyback Yield / Dilution	-0.79%	-0.17%	5.67%	-308.70%	-113.98%	-0.52%
Total Shareholder Return	-0.79%	-0.17%	5.67%	-308.70%	-113.98%	-0.52%

Source: S&P Capital IQ. Standard template. Financial Sources.